UCSF Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Deadline: Nov 15
Damon Runyon Clinical Investigator Award 2025
This program supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. - Deadline: Nov 15
Mary Kay Ash Foundation 2025 Innovative/Translational Cancer Research Grant
This program funds innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian, uterine or cancers predominantly affecting women.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: Nov 15, 2024
Upstream Research Center Pilot Grants
The Upstream Research Center (co-led by Stanford, UC Davis, and UC San Francisco) has released a third round of requests for pilot proposals to catalyze research aimed at reducing cancer inequities due to structural and social determinants of health, including, but not limited to, structural racism, poverty, income inequality, climate change, food insecurity, social isolation, and housing insecurity. - Deadline: Dec 1, 2024
UC Pancreatic Cancer Consortium Early Detection Awards
This program will fund up to two 2-year pilot projects in novel areas of early detection for pancreatic cancer. The goal is to promote the highest quality clinical, basic, or population science with translational potential. Projects must propose highly original strategies to address the challenges of early detection in pancreatic cancer and not simply represent new applications of single analyte biomarkers. Examples may include immune sensing of early neoplastic changes, novel multi-analyte biomarkers, or AI-driven large-scale interrogation of the EMR, however, the review committee is open to all innovative ideas. - Deadline: Jan 15, 2024
HDFCCC Bladder Cancer Research Hub RFA
The Bladder Cancer Research Hub is requesting applications from HDFCCC members for pilot research projects. Priority areas to be funded include: research addressing strategic goals of the Bladder Cancer Program (see RFA for details), cross-disciplinary research and investigators who have not previously collaborated, and projects addressing health disparities.
Foundations/Other Sources
- LOI Deadline: Dec 4, 2024
BCRF-AACR Career Development Awards to Promote Diversity and Inclusion
The Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and Inclusion represent a focused effort to encourage and support investigators from diverse backgrounds who are underrepresented in cancer research and/or from low resource settings, and to foster their professional advancement. This grant program also intends to build a more diverse and inclusive future for breast cancer research. - Deadline: Jan 6, 2025
NCCN Phase I/II Clinical Trials of Zipalertinib (CLN 081/TAS 6417) for Non-Small Cell Lung Cancers with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Uncommon/Compound Mutations
The National Comprehensive Cancer Network (NCCN) and Taiho Oncology, Inc. are collaborating to offer a new grant opportunity seeking proposals for investigator-initiated
research with Zipalertinib.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
- Due January 23, 2025: NCI Administrative Supplements to Support Cancer Disparity Collaborative Research
To view NCI funding opportunities, search here